The human transferrin detection kit market is projected to grow from USD 557.9 million in 2025 to USD 962.0 million by 2035, at a CAGR of 5.6%. Immunoturbidimetric assay kit will dominate with a 58.0% market share, while hospitals will lead the application segment with a 68.0% share.